TY  - JOUR
AU  - Macias, Rocio I R
AU  - Banales, Jesus M
AU  - Sangro, Bruno
AU  - Muntané, Jordi
AU  - Avila, Matias A
AU  - Lozano, Elisa
AU  - Perugorria, Maria J
AU  - Padillo, Francisco J
AU  - Bujanda, Luis
AU  - Marin, Jose J G
PY  - 2017
DO  - 10.1016/j.bbadis.2017.08.002
SN  - 0925-4439
UR  - http://hdl.handle.net/10668/11480
T2  - Biochimica et biophysica acta. Molecular basis of disease
AB  - The poor prognosis of cholangiocarcinoma (CCA) is in part due to late diagnosis, which is currently achieved by a combination of clinical, radiological and histological approaches. Available biomarkers determined in serum and biopsy samples to assist...
LA  - en
KW  - Biliary cancer
KW  - Biomarker
KW  - Differential diagnosis
KW  - Liver cancer
KW  - Omics
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - Bile Duct Neoplasms
KW  - Bile Ducts
KW  - Biomarkers, Tumor
KW  - Biopsy
KW  - Cholangiocarcinoma
KW  - Epigenomics
KW  - Gene Expression Profiling
KW  - Humans
KW  - Immunotherapy
KW  - Metabolomics
KW  - Neoplasm Recurrence, Local
KW  - Prognosis
KW  - Proteomics
KW  - Survival Rate
KW  - Treatment Outcome
TI  - The search for novel diagnostic and prognostic biomarkers in cholangiocarcinoma.
TY  - research article
VL  - 1864
ER  -